| Similar Articles |
|---|
 |
Nurse Practitioner
May 2010
Townsend-Roccichelli et al. |
Managing sleep disorders in the elderly This article will provide an overview of sleep physiology in the aging population, identify common sleep disorders, and suggest pharmacologic and nonpharmacologic treatment options.   |
Nurse Practitioner
August 2009
Fisher & Valente |
Evaluating and managing insomnia Insomnia is the most frequent complaint in sleep disorders, and in the past, it had been viewed as a transient problem related only to other medical issues. That line of thought has changed |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nurse Practitioner
January 2012
Hedges & Ruggiero |
Treatment Options for Insomnia Nurse practitioners must be prepared to screen patients for this common sleep disorder as well as understand the latest treatment options for optimal patient outcomes. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
American Family Physician
January 15, 2003
Ables & Baughman |
Antidepressants: Update on New Agents and Indications Many antidepressants have been released in the United States over the past two decades. This article is an update of information about the newer agents for depression and new indications for older antidepressants. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
Chemistry World
June 14, 2012
Andrew Turley |
Good signs for Merck & Co insomnia pill In Phase III trials, insomnia drug candidate suvorexant performed well, reducing the time patients needed to fall asleep and increasing the total time sleeping, with some patients benefitting from the very first night of treatment. |
Managed Care
November 2006
Martin Sipkoff |
Successful Treatment of Insomnia Starts With Formulary Design Many insurers may not consider insomnia a serious health problem, but it costs employers a bundle in lowered productivity. |
American Family Physician
April 15, 2003
Hadley & Petry |
Valerian Valerian improves subjective experiences of sleep when taken nightly over one- to two-week periods, and it appears to be a safe sedative/hypnotic choice in patients with mild to moderate insomnia. |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
American Family Physician
June 15, 2002
Jeffrey L. Cummings |
Guidelines for Managing Alzheimer's Disease: Part II. Treatment Once the clinical diagnosis of Alzheimer's disease has been made, a treatment plan must be developed. Patient symptoms and care needs change as Alzheimer's disease progresses. |
American Family Physician
October 15, 2002
Zamorski & Albucher |
What to Do When SSRIs Fail: Eight Strategies for Optimizing Treatment of Panic Disorder Effective management of panic disorder is a common challenge for family physicians. Selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice for this condition because of their safety and efficacy. But not all patients have a favorable response to SSRI therapy. |
American Family Physician
August 1, 2002
Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
American Family Physician
November 1, 2000
Sharon Scott Morey |
Guidelines on Migraine: Recommendations for Individual Drugs The following is an excerpt of the section in the migraine guidelines that outlines the findings from clinical studies and the specific recommendations for individual drugs... |
American Family Physician
February 15, 2002
Donald W. Lewis |
Headaches in Children and Adolescents Headaches are common during childhood and become more common and increase in frequency during adolescence. The rational, cost-effective evaluation of children with headache begins with a careful history... |
AskMen.com
Kristen Armstrong |
Insomnia Causes And Treatments Insomnia can wreak havoc on a person's life. Sufferers can try meditation, exercise or relaxation methods to alleviate symptoms and enjoy long, restful sleep on a nightly basis. |
AskMen.com
Dustin Driver |
Sleeping Pills You have a lot of options when it comes to sleeping pills. Take a look at this list of some of the most commonly prescribed sleeping pills before you make any decisions. |
American Family Physician
December 1, 2004
McConaghy & Smith |
Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. |
American Family Physician
December 1, 2000
Sharon Scott Morey |
Guidelines on Migraine Recommendations for Specific Prophylactic Drugs... |
BusinessWeek
January 17, 2005
Weintraub & Barrett |
Waking Up The Insomnia Market On Dec. 16, Sepracor Inc. won approval from the Food & Drug Administration to market Lunesta, a new sleep aid. Giddy investors pushed Sepracor's stock up 16%, to $60, in the two weeks following the news. |
American Family Physician
October 1, 2005 |
Insomnia: How to Get a Good Night's Sleep A patient guide to the condition and what to do to improve outcomes. |
Pharmaceutical Executive
October 1, 2010 |
Optimizing TV Advertising Placements & Results Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives. |
BusinessWeek
January 26, 2004
Arelene Weintraub |
"Exploring New Paradigms in Sleep" Two top execs from Sanofi, maker of the popular drug Ambien, talk about the challenges of staying on top in the insomnia market. |
BusinessWeek
January 26, 2004
Arlene Weintraub |
"I Can't Sleep" Insomnia and other sleep disorders are wreaking havoc on our health and taxing the economy. Drug companies see an opportunity. |
The Motley Fool
February 17, 2005
Karl Thiel |
Sleeping on Neurocrine's Shares Why haven't Neurocrine Biosciences shares moved? It's partly history, with delays in getting an insomnia drug to market. |
The Motley Fool
August 13, 2004
Charly Travers |
Smaller Market for Insomnia Drugs A market research report shows insurers might not cover some drugs for this condition. |
AskMen.com
Dustin Driver |
Sleep Disorders Explained Sleep disorders can do more than just make you drowsy; if untreated, they can cause high blood pressure, increased heart rate and heart disease. And the first step in treatment is identification. |
ifeminists
September 14, 2005
Tony Zizza |
Lunesta Lunacy Big Pharma will not stop telling us that we need countless prescription medicines to treat all that troubles us unless we actually take the time to listen to what we're being told. To believe that as adults we need Lunesta to cope with electric bills is lunacy. |
